Renal Cancer - Results from #4620

Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study February 16, 2018

Durable clinical benefit in metastatic renal cell carcinoma patients who discontinue PD-1/PD-L1 therapy for immune-related adverse events (irAEs) February 15, 2018

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma February 15, 2018

MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway February 13, 2018

Twist2 and CD24 expression alters renal microenvironment in obesity associated kidney cancer February 13, 2018

A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC) February 13, 2018

Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma February 12, 2018

Outcomes of synchronous and metachronous bilateral small renal masses (< 4 cm): a population-based cohort study. February 12, 2018

Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study February 12, 2018

Acute Kidney Injury in Cancer Patients February 9, 2018

Accuracy of kidney cancer diagnosis and histological subtype within Canadian cancer registry data February 8, 2018

Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms. February 8, 2018

RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition February 8, 2018

Eosinophilic Solid and Cystic Renal Cell Carcinoma: Imaging Features of a Novel Neoplasm February 7, 2018

Advanced native-kidney carcinoma in a heart- and kidney-transplanted patient: a case report February 7, 2018

Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials February 7, 2018

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma February 7, 2018

A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1. February 6, 2018

Surgical management of renal cell carcinoma with levels III and IV tumor thrombus using the « flush » technique. February 6, 2018

MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1 February 5, 2018

Page 232 of 456